Clinical trial · Observational
Validation of the ASI-SR Form in a Population of Chronic Non-cancer Pain Patients
ASI-SR Form as a Standardized Instrument for Healthcare Management of Chronic Non-cancer Pain Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Recruitment failure
Summary
Brief summary (as posted)
The Swedish version of ASI-SR has shown good feasibility in assessment of addiction patients functioning compare to long and time-consuming ASI, which is upp to date golden standard in Sweden. This study investigate if ASI-SR is suitable instrument for the assessment of the chronic pain patient addicted to opioids. The validation process is designed according to the COSMIN guidelines. Preliminary results are expected by December 2022.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Assessment, Self | — | UNRESOLVED | — |
| Chronic Pain | — | UNRESOLVED | — |
| Opioid-use Disorder | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
| Risk Reduction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ASI-SR | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Chronic pain
- description
- Patients with chronic non-cancer pain referred to secondary and tertiary care
- interventionNames
- Diagnostic Test: ASI-SR
Primary outcomes (1)
- measure
- Addiction Severity Index - Short version
- timeFrame
- Baseline
- description
- The main objective with this study is to test the psychometric properties of the ASI-SR in a population of CNCP patients.Consistency of CS between the interview and the self-report will be evaluated on the individual basis by interclass correlation analysis (ICC) and at group level with paired t-test or Wilcoxon signed rank test if data is not normally distributed. ICC coefficient is considered to be poor if it is less than 0.40, fair between 0.40-0.59 , good between 0.60-0.70 and excellent between 0.75-1.00.
Secondary outcomes (8)
- measure
- Patient Global Impression of Change
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Chronic non-cancer related pain * ongoing treatment in the clinic Exclusion Criteria: * severe cognitive impairment * illiterate in Swedish * inability to give informed consent.
References
Publications (0)
Data not yet available